Clinical research has shown participants losing up to 24% of their body weight over 48 weeks
Recent clinical findings show that retatrutide demonstrates strong therapeutic potential in type 2 diabetes research
The well-documented association between metabolic conditions, such as type 2 diabetes mellitus (T2DM) and obesity, and the risk of dementia has created opportunities for repurposing metabolic drugs for neurological disorders (Long and Holtzman, 2019)
If I can see my body represented elsewhere, maybe Im okay, maybe Im safe, maybe I could just exist, maybe I could stop dieting, maybe I can just live in this larger body. When an influencer loses weight, it can erode or challenge a persons belief system, she explains
In large part, that rebound was fueled by increasing demand for weight-loss drugs such as GLP-1 agonists and semaglutide treatments, including Ozempic, Wegovy, Zepbound, and Mounjaro